Full-Time

Patient Care Coordinator Lead

Inbound

Posted on 8/18/2026

Orsini Healthcare

Orsini Healthcare

201-500 employees

Independent specialty pharmacy for rare diseases

Compensation Overview

$25/hr

Elk Grove Village, IL, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Customer Service
Excel/Numbers/Sheets

Get referred to Orsini Healthcare

See people who can refer or advise you

Requirements
  • Three or more years of experience in a pharmacy setting.
  • A state pharmacy technician license is required.
  • National technician certification is required.
  • Experience providing customer service to patients in a pharmacy setting.
  • Experience with data entry and computer systems for prescriptions and medical records.
  • Intermediate knowledge of Microsoft Excel.
  • Ability to meet or exceed departmental performance metrics and goals.
  • Ability to multitask and complete work accurately with attention to detail.
  • Ability to lead the team in the absence of a supervisor or manager.
Responsibilities
  • Establish and continually build rapport with the patient base.
  • Monitor medication compliance and persistence.
  • Triage patients to pharmacists when needed.
  • Provide customer service to internal and external customers.
  • Process and verify patient information, benefits, and payment options as needed.
  • Respond to patient requests to refill medication orders.
  • Enter and update changes to patient medical records or orders in the relevant systems.
  • Update tracking logs with order status and shipping information.
  • Use pharmacy systems to complete the end-to-end order process.
  • Ensure timely processing of all patient orders according to committed time frames.
  • Assist with picking, packaging, and shipping patient orders as needed.
  • Collaborate with admissions and physician offices.
  • Contact patients, family members, and caregivers to schedule deliveries and determine supply needs.
  • Assist with picking and packing medication or medical supplies to fill patient orders as needed.
  • Accurately enter prescription data into the computer system.
  • Complete the order-to-ship process for patients.
  • Assist the pharmacist with completing orders for shipment.
Desired Qualifications
  • Specialty pharmacy experience is preferred.

Orsini Healthcare is a specialty pharmacy that provides targeted, patient-centered care for people with rare diseases, gene therapies, and complex conditions. Its service model centers on high-touch, therapy-specific care teams that offer personalized support to patients based on their particular treatment. The company runs comprehensive programs that improve medication adherence, uses data analytics, and coordinates customized manufacturer programs. It also provides nationwide nursing coverage for in-home infusion services. Orsini is independent and headquartered in Elk Grove Village, Illinois, with accreditations from ACHC, NABP, and ACHC’s Distinction in Rare Diseases and Orphan Drugs. Through its focused condition list—such as Pompe disease, Duchenne Muscular Dystrophy, MPS, Fabry disease, SMA, HAE, PKU, and other rare disorders—the company aims to make complex therapies easier to access and manage for patients across the United States.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Elk Grove Village, Illinois

Founded

2004

Get referred to Orsini Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 2026 launches for Hepcludex, AVLAYAH, and LOARGYS expand Orsini's contracted volume.
  • Columbus opened October 2025, adding redundancy for cell and gene therapies.
  • Gene-therapy distribution for LYFGENIA, ZYNTEGLO, and SKYSONA widens Orsini's center-of-excellence footprint.

What critics are saying

  • Orsini depends on niche launches like Hepcludex, AVLAYAH, LOARGYS, and Epioxa.
  • Rare-disease exclusivity invites payer squeeze if Gilead, Denali, or Glaukos rebid.
  • A 2025 data-incident settlement signals recurring cyber exposure and reputational drag.

What makes Orsini Healthcare unique

  • Orsini built a rare-disease platform since 1987, spanning pharmacy, home infusion, 3PL.
  • Columbus facility now dispenses in 50 states with ultra-cold storage for gene therapies.
  • ORBIT Track gives biopharma partners real-time case visibility and HIPAA-secure collaboration.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Holidays

Tuition Reimbursement

Remote Work Options

Hybrid Work Options

Life Insurance

Company News

PR Newswire
May 26th, 2026
Orsini becomes contracted specialty pharmacy for Gilead's hepatitis delta drug Hepcludex

Orsini, a specialty pharmacy focused on rare diseases, has been selected as the contracted specialty pharmacy for Gilead's Hepcludex (bulevirtide-gmod), a treatment for chronic hepatitis delta virus infection in adults. The therapy received accelerated FDA approval for patients without cirrhosis or with compensated cirrhosis. Hepatitis delta, a co-infection affecting people with hepatitis B, is the most severe form of viral hepatitis and impacts approximately 40,000 people in the US. Hepcludex is a first-in-class entry inhibitor delivered via subcutaneous injection that demonstrated statistically significant improvement in clinical trials. Orsini, operating since 1987, specialises in rare disease pharmacy solutions and gene therapies, providing distribution, patient services and home infusion services.

PR Newswire
Apr 20th, 2026
Orsini becomes exclusive specialty pharmacy partner for Denali's Hunter syndrome therapy AVLAYAH

Orsini has been selected as the exclusive specialty pharmacy and home infusion partner for Denali Therapeutics' AVLAYAH (tividenofusp alfa-eknm), an FDA-approved enzyme replacement therapy for treating neurologic manifestations of Hunter syndrome in paediatric patients. AVLAYAH is a brain-penetrant therapy designed to break down glycosaminoglycans, sugar molecules that accumulate in patients with mucopolysaccharidosis type II (MPS II), a genetic metabolic condition causing progressive cellular damage affecting physical abilities, organ function and cognitive development. Orsini will provide comprehensive home infusion support, allowing patients to receive therapy at home under healthcare provider supervision. The treatment marks the fifth MPS therapy in Orsini's Neurology Centre of Excellence, which has served MPS patients for over 16 years.

PR Newswire
Mar 23rd, 2026
Orsini named single-source specialty pharmacy partner for Glaukos' keratoconus treatment Epioxa

Orsini has been named the single-source specialty pharmacy partner for Glaukos' Epioxa, a novel corneal cross-linking treatment for keratoconus, a rare eye disease that thins the cornea and causes vision distortion. Epioxa, which received FDA approval in October 2025, is an oxygen-enriched topical therapy bioactivated by UV light. Unlike traditional procedures, it does not require removal of the corneal epithelium, reducing pain and streamlining recovery whilst delivering clinical outcomes. Orsini, a specialty pharmacy focused on rare diseases since 1987, has partnered with Glaukos for over five years serving the keratoconus community. The company provides integrated pharmacy solutions including distribution, patient services and home infusion for rare disease treatments.

Yahoo Finance
Mar 9th, 2026
Orsini named exclusive specialty pharmacy partner for Immedica's ARG1-D treatment LOARGYS

Orsini has been selected as the exclusive specialty pharmacy and hub services partner for LOARGYS (pegzilarginase-nbln) by Immedica Pharma US Inc. LOARGYS is the first therapy approved to lower arginine in patients aged two years and older with Arginase 1 Deficiency, an ultra-rare metabolic disease affecting approximately 250 people in the US. Through this partnership, Orsini will assist patients, caregivers and healthcare providers with medication access, insurance coverage and financial assistance. The company will also provide third-party logistics services for Immedica. LOARGYS is indicated for treating hyperargininemia in adult and paediatric patients with ARG1-D, used alongside dietary protein restriction. Clinical trials showed hypersensitivity reactions occurred in 13% of treated subjects, with life-threatening reactions possible including anaphylaxis.

PR Newswire
Apr 25th, 2025
Orsini Expands Biopharma Solutions With Orbit Track™ To Enhance Partner Collaboration And Patient Case Management

ELK GROVE VILLAGE, Ill., April 25, 2025 /PRNewswire/ -- Orsini, a leader in rare disease pharmacy solutions, announced today the launch of ORBIT Track™, an innovative, next-generation portal designed to transform how Orsini connects with biopharma partners. This powerful platform delivers real-time visibility into critical patient case information and streamlined collaboration tools to enhance care for patients living with rare and complex conditions.This launch builds upon the momentum of the 2024 launch of ORBIT (Orsini Rare Business Intelligence Technology). ORBIT Track™ will further strengthen the company's data-first ecosystem, built to improve outcomes for rare disease patients and partners alike.Key features of ORBIT Track™ include:Real-Time Case Visibility: Accelerate patient access to treatment with up-to-the-minute updates on case progress and milestones.Accelerate patient access to treatment with up-to-the-minute updates on case progress and milestones. Smart Collaboration Tools: Share updates and alerts through secure HIPAA-compliant messaging to streamline collaboration between biopharma partners and Orsini.Share updates and alerts through secure HIPAA-compliant messaging to streamline collaboration between biopharma partners and Orsini. Actionable Case Insights: Access comprehensive patient progress updates, benefits information and medical documentation in one centralized location.Access comprehensive patient progress updates, benefits information and medical documentation in one centralized location. Next-Level Data Security: Protect patient information through both role-based access aligned by territory and PHI masking capabilities.Protect patient information through both role-based access aligned by territory and PHI masking capabilities